Yatharth Hospital IPO

Yatharth Hospital and Trauma Care Services Limited

₹14,250 /50 sharesMinimum Investment

Yatharth Hospital IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹300.00₹306.00₹6.00 (2.00%)

Yatharth Hospital IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
26 Jul ‘23 - 28 Jul ‘23₹14,25050₹285 - ₹300
Issue SizeIPO Doc
687.00Cr
RHP PDF

Subscription Status As on 28 Jul '23, 5:00 PM

  • Qualified Institutional Buyers
    85.10x
  • Non-Institutional Investor
    37.22x
  • Retail Individual Investor
    8.33x
  • Total
    36.15x

About Yatharth Hospital

Incorporated in 2008, Yatharth Hospital and Trauma Care Services specialises in a comprehensive array of healthcare facilities, covering the entire spectrum from primary to tertiary care and is among the top 10 largest private hospitals in the National Capital Region of Delhi. The company currently operates three state-of-the-art super speciality hospitals strategically located in Delhi NCR, with branches in Noida, Greater Noida, and Noida Extension, Uttar Pradesh. The hospital is well known for offering world-class treatment and care from the specialised Centres of Excellence (COE). These COEs include the Centre of Medicine, Centre of General Surgery, Centre of Gastroenterology, Centre of Cardiology, Centre of Nephrology & Urology, Centre of Pulmonology, Centre of Neurosciences, Centre of Paediatrics, Centre of Gynaecology, Centre of Orthopaedics, and Spine & Rheumatology.;
Parent Organisation
Yatharth Hospital and Trauma Care Services Limited
Founded
2008
Managing Director
Mr. Kapil Kumar

Strengths & Risks

  • Yatharth Hospital and Trauma Care Services operates two prominent medical facilities: Noida Extension Hospital and Greater Noida. These hospitals are the eighth and tenth largest private healthcare institutions in Delhi NCR for 2023.
  • In 2021, the hospital completed 4,535 surgeries, which increased to 8,218 surgeries in 2022 and reached 16,165 surgeries in 2023. Similarly, their dialysis procedures also witnessed a substantial upswing, with 9,132 procedures in 2021, 10,114 in 2022, and 15,359 in fiscal year 2023.
  • The hospital's diverse clientele includes entities like ESIC, EGHS, and ECHS, as well as public and private insurance companies, institutions, corporates, and walk-in patients.
  • The hospital adheres to the guidelines set by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), maintaining optimal nurse-to-patient ratios in critical treatments, such as ventilator patients and those in critical care units.
  • The hospital has well-equipped laboratories in all its facilities, catering to essential diagnostic services in hematology, biochemistry, microbiology, molecular biology, and histopathology.
  • The Greater Noida and Noida extension hospitals have received additional accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL).
  • The hospital also plans to introduce new specialities, including radiation therapy, to their oncology department at their Noida Extension and Jhansi Orchha hospitals.
  • The company relies heavily on bank and financial institution financing to sustain its business operations. It may adversely affect their financial condition if they fail to secure additional financing on favorable terms.
  • Yatharth Hospital's subsidiaries have previously incurred net losses and may struggle to attain or maintain profitability in the future.
  • The company's operations are primarily concentrated in the Delhi NCR region. Any disruptions to revenue streams from these hospitals or earnings from top specialities could significantly impact the company's overall business.
  • Inadequate hospital occupancy rates may hinder the generation of satisfactory returns on the company's capital expenditures.
  • The company faces certain contingent liabilities that could negatively affect its business.
  • The company relies on third-party suppliers and manufacturers for its supplies and equipment. Non-performance or failure to meet obligations by these third parties could negatively affect the company's business.
  • The company faces potential risks concerning handling personal information, including medical data, which could lead to regulatory and legal challenges.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular285 - 300₹2 Lakh
High Networth Individual285 - 300₹2 - 5 Lakh
For Yatharth Hospital IPO, eligible investors can apply as Regular.
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW